Norges Bank
TXG icon

Norges Bank’s 10x Genomics TXG Stock Holding History

Norges Bank’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
+72,674
New +$1.9M ﹤0.01% 1455
2026
Q1 		– Sell
-72,674
Closed -$1.19M – 1315
2025
Q4 		$1.19M Buy
+72,674
New +$1.1M ﹤0.01% 1492
2025
Q3 		– Sell
-72,674
Closed -$842K – 1466
2025
Q2 		$842K Sell
72,674
-35,886
-33% -$327K ﹤0.01% 1568
2025
Q1 		$948K Buy
108,560
+16,981
+19% +$214K ﹤0.01% 1628
2024
Q4 		$1.32M Buy
91,579
+50,508
+123% +$797K ﹤0.01% 1729
2024
Q3 		$927K Sell
41,071
-949,980
-96% -$19.6M ﹤0.01% 1737
2024
Q2 		$19.3M Buy
991,051
+116,060
+13% +$3.04M ﹤0.01% 1224
2024
Q1 		$32.8M Buy
874,991
+226,995
+35% +$9.97M 0.01% 1110
2023
Q4 		$36.3M Buy
647,996
+360,498
+125% +$15.7M 0.01% 1050
2023
Q3 		$11.9M Sell
287,498
-293,046
-50% -$15.2M ﹤0.01% 1403
2023
Q2 		$32.4M Sell
580,544
-176,096
-23% -$9.53M 0.01% 1057
2023
Q1 		$42.2M Sell
756,640
-138,407
-15% -$6.46M 0.01% 914
2022
Q4 		$32.6M Buy
895,047
+85,712
+11% +$2.8M 0.01% 1026
2022
Q3 		$23M Buy
809,335
+87,706
+12% +$3.34M 0.01% 1139
2022
Q2 		$32.7M Buy
721,629
+4,761
+0.7% +$247K 0.01% 991
2022
Q1 		$54.5M Sell
716,868
-18,883
-3% -$1.65M 0.01% 831
2021
Q4 		$110M Sell
735,751
-9,655
-1% -$1.48M 0.02% 574
2021
Q3 		$109M Buy
745,406
+82,713
+12% +$14.2M 0.02% 583
2021
Q2 		$130M Buy
662,693
+229,846
+53% +$41.6M 0.03% 547
2021
Q1 		$78.3M Buy
+432,847
New +$74.7M 0.02% 738
2020
Q4 		– Sell
-20,000
Closed -$2.49M – 2163
2020
Q3 		$2.49M Hold
20,000
– – ﹤0.01% 1947
2020
Q2 		$1.79M Hold
20,000
– – ﹤0.01% 1970
2020
Q1 		$1.25M Hold
20,000
– – ﹤0.01% 1962
2019
Q4 		$1.52M Hold
20,000
– – ﹤0.01% 2000
2019
Q3 		$1.01M Buy
+20,000
New +$1.11M ﹤0.01% 2035

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank's TXG Position: Q2 2026 in Review

Norges Bank opened a new position in 10x Genomics (TXG) in Q2 2026: 72,674 shares worth $2.79M. The stake represents ﹤0.01% of the portfolio and ranks #1455 among its holdings. This is a return to the name: Norges Bank previously reported a position in TXG as recently as Q4 2025.

Norges Bank first reported a position in TXG in Q3 2019 and has held it in 25 quarters since. The position peaked at $130M in Q2 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Norges Bank held 72,674 shares of 10x Genomics worth $2.79M as of Q2 2026.
  • 10x Genomics was a new Norges Bank position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1455 holding.
  • Norges Bank first reported a position in 10x Genomics in Q3 2019 and has held it in 25 quarters since.
  • Norges Bank's 10x Genomics position peaked at $130M in Q2 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.